Bacteriochlorin Synthesis via Segmented Pyrrole Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methodologies for synthesizing bacteriochlorins are limited, and there is no established total synthesis of bacteriochlorophylls, hindering the development of effective diagnostic and therapeutic applications, particularly in photodynamic therapy and flow cytometry.

Innovation Solution

A method for synthesizing compounds of Formula I, including metal conjugates, by condensing pairs of compounds of Formula II in an organic solvent with an acid, allowing for the production of bacteriochlorins that can be used as luminescent agents in flow cytometry and photodynamic therapy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional biosynthesis-based routes or modifications of existing natural bacteriochlorophylls are used, then the synthesis process is relatively straightforward, but the methodological limitations prevent de novo synthesis of stable bacteriochlorins and total synthesis of bacteriochlorophylls has never been achieved

Engineering Contradiction:
Improveease of synthesisVSAvoidsynthetic methodology versatility
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The synthesis is divided into two independent halves: one synthesizing the first pyrrole ring half and the other synthesizing the second pyrrole ring half. These segmented halves are then coupled together to form the complete bacteriochlorin macrocycle. This segmentation allows each half to be optimized independently and enables versatile substitution patterns at different positions.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A dipyrromethene intermediate is employed as a mediator in the macrocyclization process. This intermediary compound facilitates the coupling of the two pyrrole ring halves and enables the formation of the bacteriochlorin core structure with controlled substitution patterns.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Adaptability or versatility

If de novo synthesis of stable bacteriochlorins is attempted with limited methodologies, then some synthetic analogues have been achieved, but total synthesis of bacteriochlorophylls remains impossible

Engineering Contradiction:
Improvesynthetic methodology versatilityVSAvoidsynthesis precision
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

Different substitution patterns are introduced at specific positions (R1-R8) of the bacteriochlorin macrocycle by controlling the substitution patterns on the pyrrole ring halves before coupling. This local quality control allows precise placement of substituents including fused ring systems at specific positions, achieving manufacturing precision in the final product structure.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The method accommodates asymmetric substitution patterns by independently functionalizing the two pyrrole ring halves before coupling. This asymmetry principle enables the synthesis of bacteriochlorins with substituted positions at R1-R8, including cases where R1 and R2 together form fused aromatic or heteroaromatic ring systems, achieving diverse and precise molecular architectures.

Inventive Principle:
Principle #4Asymmetry

3Productivity

If bacteriochlorins are developed for diagnostic and therapeutic applications, then potential benefits in flow cytometry and photodynamic therapy are achieved, but the lack of established total synthesis methods hinders effective development

Engineering Contradiction:
Improveapplication development productivityVSAvoidsynthesis accessibility
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The pyrrole ring halves are synthesized and functionalized in advance with desired substitution patterns before the macrocyclization step. This preliminary action on the building blocks enables efficient assembly of the final bacteriochlorin product with predetermined properties, accelerating application development while maintaining synthesis accessibility.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The synthetic methodology provides a universal platform for generating diverse bacteriochlorin analogues with different substitution patterns. This multi-functional approach allows the same core methodology to produce various compounds suitable for different applications including flow cytometry probes and photodynamic therapy agents, enhancing both productivity and accessibility.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the effective detection and treatment of hyperproliferative tissues and various diseases, including cancer, by utilizing bacteriochlorins that preferentially associate with target tissues and are activated by specific light wavelengths, enhancing diagnostic and therapeutic outcomes.

Implementation Method 1

Bacteriochlorophylls feature a strong (ε ̃105 M−1 cm−1) long-wavelength absorption band located in the near-infrared region (NIR), normally around 700-900 nm

Methodology Applied
Scientific EffectLight absorption: Absorption (EM radiation)

Implementation Method 2

utilizing a bacteriochlorin as described herein as the luminescent compound

Methodology Applied
Scientific EffectLuminescence: Luminescence

Implementation Method 3

irradiating the target with light of a wavelength and intensity sufficient to activate the compound, and thereby treat the target

Methodology Applied
Scientific EffectPhotodynamic activation: Photosynthesis

Data Source

PatentUS10919904B2Northern-southern route to synthesis of bacteriochlorins
Publication Date: 2021.02.16 NORTH CAROLINA STATE UNIV
  • US10919904B2 patent drawing
  • US10919904B2 patent drawing
  • US10919904B2 patent drawing

AI summary

Described herein are chlorins, bacteriochlorins, methods and intermediates for the synthesis of bacteriochlorins, and methods of using such bacteriochlorins for, among other things, diagnostic and therapeutic purposes such as luminescent compounds in flow cytometry, and as active agents in photodynamic therapy (PDT).